ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Ischemia"

  • 2017 American Transplant Congress

    AAV8 Delivery of TIMP-1 Prevents Hepatocyte Apoptosis After Liver Ischemia/Reperfusion Injury.

    S. Duarte, P. Matian, M. Miller, R. Busuttil, A. Coito.

    Dumont-UCLA Transplant Center, Los Angeles

    Matrix metalloproteinase-9 (MMP-9) is a key mediator of leukocyte migration across vascular barriers in hepatic ischemia/reperfusion injury (IRI). Tissue inhibitor of metalloproteinase-1 (TIMP-1) is the…
  • 2017 American Transplant Congress

    Preservation Solution Affects the Immunological Milieu in Lung Transplantation and Alters the Inflammatory Balance.

    R. Bellmàs Sanz,1 M. Seyda,1 B. Wiegmann,2 C. Neudoerfl,1 A. Haverich,2,3 C. Falk,1,4 G. Warnecke.2,3

    1Institute of Transplant Immunology, IFB-Tx, Hannover Medical School, Hannover, Germany; 2Department for Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany; 3German Center for Lung Research (DZL), Hannover, Germany; 4German Center for Infection Research (DZIF), Hannover, Germany

    Background: The pro-/ anti-inflammatory balance in lung transplantation is shaped by the pulmonary immune compartments, i.e. the T and NK cell repertoire. At present, it…
  • 2017 American Transplant Congress

    Neutering Worsens Liver Ischemia/Reperfusion Injury in Both Male and Female Mice.

    D. Murken,1 D. Aufhauser Jr,1 S. Concors,1 Z. Wang,1 G. Ge,1 W. Hancock,2 M. Levine.1

    1Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA; 2Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA

    Introduction: Ischemia/reperfusion injury (IRI) causes significant morbidity in liver transplantation and other surgical scenarios. A better understanding of the molecular mechanisms of IRI is required…
  • 2017 American Transplant Congress

    Impact of STEEN vs Gelofusine as Perfusate During Normothermic Ex Vivo liver Perfusion on Outcome of Pig Liver Transplantation.

    I. Linares, D. Kollmann, J. Echeverri, M. Kaths, R. Rosales, C. Bruguera, M. Hamar, P. Urbanellis, S. Ganesh, N. Selzner, M. Selzner.

    Multiorgan Transplant Program, Toronto General Hospital, Toronto, ON, Canada

    European and North American clinical trials have used two different perfusate solutions for normothermic ex vivo liver perfusion (NEVLP): Gelofusine (bovine derived gelatin-based solution) and…
  • 2017 American Transplant Congress

    Neuropeptide PACAP Prevents Hepatocyte Damage by Promoting Yes-Associated Protein (YAP) in Mouse Liver Ischemia/Reperfusion Injury.

    Y. Liu,1,2 C. Zhang,1,3 R. Busuttil,1 J. Kupiec-Weglinski,1 Q. Xia,1,2 H. Ji.1

    1Department of Surgery, Dumont-UCLA Transplant Center, Los Angeles, CA; 2Liver Surgery, Ren Ji Hospital, Shanghai Jiao Tong University, Shanghai, China; 3Liver Surgery, 1st Affiliated Hospital, Zhejiang University, Hangzhou, China

    Background: Yes-associated protein (YAP), a regulator of cellular anti-oxidation and regeneration, drives cell proliferation and promotes survival. We have previously demonstrated that neuropeptide pituitary adenylate…
  • 2017 American Transplant Congress

    Normothermic Donor Lung Preservation with Portable EVLP Significantly Reduces Ischemia/Reperfusion Injury in Lung Recipients by Promoting Cytokine Antagonists.

    C. Falk,1 B. Wiegmann,2 C. Neudörfl,1 C. Kühn,2 I. Tudorache,2 M. Wvsar,2 A. Haverich,2 G. Warnecke.2

    1Institute of Transplant Immunology, IFB-Tx, Hannover Medical School, Hannover, Germany; 2Department of Cardiothoracic Transplant and Vascular Surgery, MHH, Hannover, Germany

    ObjectivesThe INSPIRE trial revealed significant reduction of PGD grade 3 using the Organ Care System (OCS) compared to the standard of care (SOC) for lung…
  • 2017 American Transplant Congress

    The Use of a Furosemide Stress Test (FST) for Assessment of Discarded Deceased Donor Kidneys in an Ex-Vivo Normothermic Perfusion Model.

    I. Palma, Y. Smolin, S. Kabagambe, A. Perry, I. Palma, J. Sageshima, R. Perez.

    Department of Surgery, UC Davis Medical Center, Sacramento, CA

    Studies have shown that Ex-Vivo Normothermic Perfusion (EVNP) has the potential to assess viability and function of high-risk deceased donor kidneys. A diuretic response to…
  • 2017 American Transplant Congress

    Effects of the Gut-Liver Axis on Ischemia-Mediated Hepatocellular Carcinoma Recurrence in the Mouse Liver.

    L. Orci,1 S. Lacotte,1 V. Delaune,1 G. Oldani,1 F. Slits,1 C. Rossetti,2 L. Rubbia-Brandt,3 P. Morel,1 C. Toso.1

    1Hepato-pancreato-biliary Centre, Department of Surgery, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland; 2Dipartimento di Biotecnologie e Scienze della Vita, Università degli Studi dell'Insubria, Varese, Italy; 3Division of Clinical Pathology, Department of Pathology and Immunology, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland

    Background: There is growing evidence that liver graft ischemia-reperfusion (I/R) is a risk factor for hepatocellular carcinoma (HCC) recurrence after liver transplantation, but the involved…
  • 2017 American Transplant Congress

    The Polymer Pro-Drug APP-103 Mitigates I/R Injury and Improves Graft Function in a Pre-Clinical Renal Transplant Model.

    K. Minami,1,3 H. Uehara,1 A. Elkhal,1 S. Bae,3 J. Reder,2 B. Houser,2 P. Kang,3 S. Tullius.1

    1Transplant Surgery Division, Brigham and Women's Hospital, Boston, MA; 2Celdara Medical, LLC, Lebanon, NH; 3Beth Israel Deaconess Medical Center, Boston, MA

    Purpose: Ischemia-reperfusion injury (IRI) is the strongest non-HLA factor that augments allogenicity of transplanted organs. Damage subsequent to IRI is critically linked to an abundance…
  • 2017 American Transplant Congress

    Kidney Injury Molecule-1 Mitigates Tissue Damage from Transplant Renal Ischemia Reperfusion Injury.

    J. Lee,1,2 X. Zhang,2 A. Haig,3 D. Lian,2 P. Anderson,2 R. Navaratnam,2 L. Gunaratnam.1,2

    1Department of Microbiology and Immunology, Western University, London, ON, Canada; 2Matthew Mailing Centre for Translational Transplant Studies, London Health Sciences Centre, London, ON, Canada; 3Department of Pathology, Western University, London, ON, Canada

    Ischemia reperfusion injury (IRI) at the time of organ harvesting is unavoidable, may cause delayed renal graft function, and is associated with premature graft loss.…
  • « Previous Page
  • 1
  • …
  • 33
  • 34
  • 35
  • 36
  • 37
  • …
  • 45
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences